ACADIAN ASSET MANAGEMENT LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$10,187,000
-67.9%
235,752
-68.6%
0.06%
-63.6%
Q2 2015$31,739,000
-39.4%
751,046
-44.4%
0.15%
-36.4%
Q1 2015$52,396,000
+17.7%
1,351,097
+2.2%
0.24%
+22.2%
Q4 2014$44,514,000
-2.0%
1,322,080
+1.9%
0.20%
-9.6%
Q3 2014$45,424,000
-32.0%
1,297,121
-36.1%
0.22%
-32.6%
Q2 2014$66,751,000
-26.9%
2,031,352
-18.0%
0.32%
-32.2%
Q1 2014$91,368,000
+255.6%
2,478,722
+270.2%
0.48%
+235.0%
Q4 2013$25,697,000
+411.0%
669,595
+264.8%
0.14%
+333.3%
Q3 2013$5,029,000183,5530.03%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders